XRAY · XBRL financial data

DENTSPLY SIRONA financial statements, every fiscal year

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (XRAY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	3,342	4,231	3,922	3,965	3,793	3,680
Cost of goods and services sold	1,685	1,884	1,795	1,879	1,835	1,840
Gross profit	1,657	2,347	2,127	2,086	1,958	1,840
Research and development	115	171	174	184	165	150
Selling, general and administrative	1,435	1,551	1,589	1,613	1,605	1,438
Operating income (loss)	(12)	608	(937)	(85)	(879)	(422)
Interest income	1	—	—	—	—	—
Interest expense	48	61	65	81	69	88
Other income (expense)	(1)	(8)	(58)	(9)	12	24
Income tax expense (benefit)	23	134	(105)	(43)	(26)	112
Net income (loss)	(83)	411	(950)	(132)	(910)	(598)
Earnings per share, basic USD per share	(0.38)	1.88	(4.41)	(0.62)	(4.48)	(3.00)
Earnings per share, diluted USD per share	(0.38)	1.87	(4.41)	(0.62)	(4.48)	(3.00)
Weighted average shares, basic millions of shares	219	218	216	212	203	199
Weighted average shares, diluted millions of shares	219	220	216	212	203	199

Fiscal years (XRAY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	438	339	365	334	272	326
Inventory	466	515	627	624	564	642
Prepaid and other current assets	214	248	269	320	354	367
Total current assets	1,791	1,852	1,893	1,973	1,746	2,023
Property and equipment, net	791	773	761	800	—	—
Right-of-use asset	176	198	200	178	136	139
Goodwill	3,986	3,976	2,688	2,438	1,597	1,148
Total assets	9,342	9,239	7,643	7,370	5,753	5,429
Accounts payable	305	262	279	305	241	300
Accrued liabilities	653	760	727	749	754	700
Current portion of long-term debt	296	1	1	77	128	228
Total current liabilities	1,317	1,261	1,170	1,425	1,589	1,343
Long-term debt	1,978	1,913	1,826	1,796	1,586	2,015
Lease liability, non-current	130	149	149	125	91	93
Total liabilities	4,372	4,242	3,831	4,076	3,810	4,089
Retained earnings (accumulated deficit)	1,233	1,514	456	205	(835)	(1,564)
Total stockholders' equity	4,967	4,996	3,811	3,293	1,942	1,339
Total liabilities and equity	9,342	9,239	7,643	7,370	5,753	5,429
Common shares outstanding (cover page) millions of shares	219	218	215	207	199	200

Fiscal years (XRAY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(83)	411	(950)	(132)	(910)	(598)
Stock-based compensation	47	48	59	46	39	33
Depreciation and amortization	334	347	328	343	349	352
Net cash from operating activities	635	657	517	377	461	235
Purchases of property and equipment	87	142	149	—	—	—
Net cash from investing activities	(1,106)	(358)	(138)	(89)	(197)	(132)
Share repurchases	140	200	150	300	250	0
Dividends paid	88	92	104	116	126	128
Proceeds from long-term debt	—	16	6	0	1	553
Repayments of long-term debt	701	297	2	7	88	147
Net cash from financing activities	490	(379)	(329)	(307)	(302)	(80)
Net change in cash	33	(99)	26	(31)	(62)	54

SIC 3843 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3843 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026
Icu Medical	298	552	80*	25.0M	—	Q2 FY26 10-QJun 30, 2026
MiniMed Group	207	843	(49)	281.3M	2.3 quarters	Q1 FY27 10-QJul 31, 2026
Inspire Medical Systems	191	207	46*	29.0M	—	Q3 FY26 10-QSep 30, 2026
Masimo	125	404	45	52.4M	—	Q1 FY26 10-QApr 4, 2026
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Integer Holdings	14	450	37*	34.0M	—	Q3 FY26 10-QOct 2, 2026

Not investment advice. Not affiliated with the U.S. SEC.